825 results on '"Yahalom J"'
Search Results
2. Salvage Radiotherapy as a Bridge for Relapsed Secondary CNS Lymphoma
3. Radiation Therapy in the Management of Primary Gastric Diffuse Large B-Cell Lymphomas: Long-Term Outcomes of 82 Patients
4. Radiation in a New Era of Multiple Myeloma Management: Patterns of Utilization, Clinical, Radiologic, and Biochemical Outcomes, and Possible Genomic Correlates of Response
5. Very Low Dose Radiation Therapy for Indolent Lymphomas: Comparing “Big Boom” (4 Gy x 1) vs. “Boom Boom” (2 Gy x 2)
6. Genetic Alterations in Follicular Lymphoma Predict Response to Very Low Dose Radiotherapy
7. Radiation in a new era of Multiple Myeloma management: Patterns of utilization, clinical, radiologic, and biochemical outcomes, and possible genomic correlates of response
8. Evolving consolidation patterns and modern outcomes for a large longitudinal cohort of primary CNS lymphoma patients
9. PET‐Adapted Therapy with Nivolumab plus Adriamycin, Vinblastine, and Dacarbazine for Newly Diagnosed Stage III or IV Hodgkin Lymphoma
10. UPFRONT RADIATION THERAPY FOR POST‐STEM CELL TRANSPLANT MULTIPLE MYELOMA PATIENTS WITH OLIGO‐RELAPSE/PROGRESSIVE DISEASE: FACTORS ASSOCIATED WITH FAVORABLE OUTCOMES
11. PHASE 2 TRIAL OF NIVOLUMAB PLUS ADRIAMYCIN, VINBLASTINE, DACARBAZINE (N‐AVD) AS FRONTLINE THERAPY IN OLDER ADULTS WITH HODGKIN LYMPHOMA
12. DYNAMICS OF RADIOMIC FEATURES FOLLOWING BRIDGING THERAPY DETERMINE CD19 CHIMERIC ANTIGEN RECEPTOR (CAR) T‐CELL THERAPY OUTCOME
13. A PHASE I STUDY OF SPLIT‐COURSE BRIDGING RADIOTHERAPY (SC‐BRT) PRIOR TO COMMERCIAL CD19 CAR T‐CELL THERAPIES FOR PATIENTS WITH RELAPSED OR REFRACTORY B‐CELL LYMPHOMAS
14. Radiotherapy as an effective bridge for chemo‐refractory or progressive secondary CNS lymphoma
15. OC-0439 Consolidation patterns and associated outcomes for a large cohort of primary CNS lymphoma patients
16. Long-term outcome of 487 patients with early-stage extra-nodal marginal zone lymphoma
17. Predictors of Response to Radiation Therapy and of Progression to Multiple Myeloma in Patients with Solitary Bone and Solitary Extramedullary Plasmacytomas
18. Radiotherapy for Relapse after Chimeric Antigen Receptor T Cell Therapy in Hematologic Malignancies
19. Patterns of Relapse and Risk Reduction Following Tumor Debulking by Bridging Radiotherapy prior to Chimeric Antigen Receptor T Cell Therapy in Non-Hodgkin Lymphoma
20. Outcomes and Failure Patterns for >500 Patients Treated for Primary CNS Lymphoma: Exploring Modern Roles for Radiotherapy
21. OC-0438 Patterns of failure in 559 primary central nervous system lymphoma patients treated from 1983-2020
22. PO-1172 Irradiating the spleen for non-Hodgkin lymphoma: efficacy and tolerance
23. OC-0296 The role of radiation therapy in the treatment of primary hepatic lymphomas
24. OC-0291 Patterns of failure in primary CNS lymphoma: the MSKCC experience from 2004-2018
25. PO-1170 Low-dose radiotherapy for extranodal marginal zone lymphoma of bronchus-associated lymphoid tissue
26. Early-stage mantle cell lymphoma: a retrospective analysis from the International Lymphoma Radiation Oncology Group (ILROG)
27. A novel reduced intensity conditioning regimen for patients with high-risk hematological malignancies undergoing allogeneic stem cell transplantation
28. “Big Boom” Radiation Treatment (RT) of 4 Gy Single Fraction: Is It an Acceptable Alternative to “Boom Boom” Radiation Treatment 2 Gyx2 Fractions for Non-Hodgkin Lymphomas (NHL)?
29. Prediction of Response to Very Low Dose Radiotherapy (4 Gy) in Mature B-Cell Lymphomas Using Metabolic Tumor Volume
30. Predictors of Response to Very Low Dose Radiotherapy (4Gy) for Indolent B-Cell Lymphomas: Is 4Gy Also Suitable for Potentially Curable Patients?
31. Efficacy and Toxicity of Alternative Radiation Treatment Schemes for Patients With Hematologic Malignancies: A Collaborative ILROG COVID Era Report
32. A Proof-of-Principle Study of Split-Course Bridging Radiotherapy Prior to Commercial CD19 CAR T-Cell Therapies for Patients With Relapsed or Refractory B-Cell Lymphomas
33. Stanford V program for locally extensive and advanced Hodgkin lymphoma: the Memorial Sloan-Kettering Cancer Center experience
34. Multicenter experience with radiotherapy for relapse after chimeric antigen receptor T cell therapy in non‐Hodgkin lymphoma.
35. CNS radiotherapy as bridging prior to CAR T‐cell therapy for hematologic malignancies.
36. Predictors of response to radiation therapy and of progression to multiple myeloma in patients with solitary bone and extramedullary plasmacytomas.
37. Treatment outcomes of Limited Stage Grade 3A Follicular Lymphoma.
38. Electrodeposition of Metallic Multilayers by a Pulse Method
39. CLINICAL OUTCOMES AND THE ROLE OF OBSERVATION IN EARLY‐STAGE FOLLICULAR LYMPHOMA
40. The role of FDG-PET imaging and involved field radiotherapy in relapsed or refractory diffuse large B-cell lymphoma
41. OC-0092 Patient Selection Using Genetic Alterations Associated with Radiosensitivity In Follicular Lymphoma
42. ILROG emergency guidelines for radiation therapy of hematological malignancies during the COVID-19 pandemic
43. Involved Site Radiation Therapy in Adult Lymphomas: An Overview of International Lymphoma Radiation Oncology Group Guidelines
44. Microstructural dependence of giant-magnetoresistance in electrodeposited Cu-Co alloys
45. SP-0130: Translating partnership into optimal health: the case of ILROG
46. High Local Control And Overall Survival With Radiotherapy For Anaplastic Large Cell Lymphoma
47. Progressive disease following autologous transplantation in patients with chemosensitive relapsed or primary refractory Hodgkin's disease or aggressive non-Hodgkin's lymphoma
48. Second malignancy risk associated with treatment of Hodgkin's lymphoma: meta-analysis of the randomised trials
49. Basic fibroblast growth factor potentiates cisplatinum-induced cytotoxicity in MCF-7 human breast cancer cells
50. The International Prognostic Index predicts for outcome following autologous stem cell transplantation in patients with relapsed and primary refractory intermediate-grade lymphoma
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.